Marginal resection for osteosarcoma with effective neoadjuvant chemotherapy: long-term outcomes

World Journal of Surgical Oncology

XiuChun Yu¹  SongFeng Xu¹  Ming Xu¹ 

[1] Orthopedic Department, General Hospital of Jinan Military Commanding Region, No.25# ShiFan Street, JiNan City, Shandong Prov 250031, China

关键词: Marginal resection;    Limb salvage;    Adjuvant;    Chemotherapy;    Osteosarcoma;   

Others  :  1147399
DOI  :  10.1186/1477-7819-12-341

 received in 2014-02-07, accepted in 2014-10-29,  发布年份 2014

【 摘 要 】

Background

We report the long-term outcomes of patients with osteosarcoma who underwent effective preoperative chemotherapy and subsequently underwent marginal resection.

Methods

We reviewed the records of 50 patients with osteosarcoma who underwent marginal resection following effective preoperative chemotherapy; 18 were treated with the MMIA (high-dose methotrexate (HD-MTX), adriamycin (ADR), ifosfamide (IFO)) and cisplatin (DDP), and 32 patients were treated with the DIA (DDP, ADR and IFO). protocol. The functions of the affected limb were evaluated using the revised MSTS93 system. The Kaplan-Meier method was used for survival analysis.

Results

After a median follow-up of 5.5 years, the rates were: overall 5-year cumulative survival 61.7%, event-free survival 57.7%, recurrence 8.5%, pulmonary metastases 42.6%, and excellent to good function of the affected limb 57.7%.

Conclusions

Our results showed that marginal resection can be performed in patients with osteosarcoma who obtain clinically favorable responses to chemotherapy. Patients had a good clinical course and there was no negative effect on rates of survival or local recurrence.

【 授权许可】

   
2014 Xu et al.; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

【 参考文献 】

• [1]Tsuchiya H, Tomita K, Mori Y, Asada N, Yamamoto N: Marginal excision for osteosarcoma with caffeine assisted chemotherapy. Clin Orthop Relat Res 1999, 358:27-35.
• [2]Kanazawa Y, Tsuchiya H, Nonomura A, Takazawa K, Yamamoto N, Tomita K: Intentional marginal excision of osteosarcoma of the proximal fibula to preserve limb function. J Orthop Sci 2003, 8(6):757-761.
• [3]Huvos AG: Bone tumors: Diagnosis, treatment, and prognosis. London: WB Saunders Press; 1997.
• [4]Enneking WF, Dunham W, Gebhardt MC, Malawar M, Pritchard DJ: A system for the functional evaluation of reconstructive procedures after surgical treatment of tumors of the musculoskeletal system. Clin Orthop Relat Res 1993, 286:241-246.
• [5]Enneking WF, Spanier SS, Goodman MA: A system for the surgical staging of musculoskeletal sarcoma. Clin Orthop Relat Res 1980, 153:106-120.
• [6]Hayashi K, Tsuchiya H, Yamamoto N, Takeuchi A, Tomita K: Functional outcome in patients with osteosarcoma around the knee joint treated by minimised surgery. Int Orthop 2008, 32(1):63-68.
• [7]Yu XC, Xu M, Song RX, Xu SF: Marginal resection for osteosarcoma with effective preoperative chemotherapy. Orthop Surg 2009, 1(3):196-202.
• [8]Picci P, Mercuri M, Ferrari S, Alberghini M, Briccoli A, Ferrari C, Pignotti E, Bacci G: Survival in high-grade osteosarcoma: improvement over 21 years at a single institution. Ann Oncol 2010, 21(6):1366-1373.
• [9]Daw NC, Neel MD, Rao BN, Billups CA, Wu J, Jenkins JJ, Quintana J, Luchtman-Jones L, Villarroel M, Santana VM: Frontline treatment of localized osteosarcoma without methotrexate. Cancer 2011, 117(12):2770-2778.
• [10]Assi H, Missenard G, Terrier P, Le Pechoux C, Bonvalot S, Vanel D, Meric JB, Tursz T, Lecesne A: Intensive induction chemotherapy without methotrexate in adult patients with localized osteosarcoma: results of the Institut Gustave-Roussy phase II trial. Curr Oncol 2010, 17(6):23-23.
• [11]Ferrari S, Smeland S, Mercuri M, Bertoni F, Longhi A, Ruggieri P, Alvegard TA, Picci P, Capanna R, Bernini G, Müller C, Tienghi A, Wiebe T, Comandone A, Böhling T, Del Prever AB, Brosjö O, Bacci G, Saeter G, Italian and Scandinavian Sarcoma Groups: Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups. J Clin Oncol 2005, 23(34):8845-8852.
• [12]Fuchs N, Bielack SS, Epler D, Bieling P, Delling G, Körholz D, Graf N, Heise U, Jürgens H, Kotz R, Salzer-Kuntschik M, Weinel P, Werner M, Winkler K: Long-term results of the co-operative German-Austrian-Swiss osteosarcoma study group’s protocol COSS-86 of intensive multidrug chemotherapy and surgery for osteosarcoma of the limbs. Ann Oncol 1998, 9(8):893-899.
• [13]Bacci G, Longhi A, Ferrari S, Briccoli A, Donati D, De Paolis M, Versari M: Prognostic significance of serum lactate dehydrogenase in osteosarcoma of the extremity: experience at Rizzoli on 1421 patients treated over the last 30 years. Tumori 2004, 90:478-484.